The fee-for-service payment model has drawn fire in recent years for rewarding volume rather than value. The Relative Value Unit (RVU) that serves as a foundation for many physicians compensation also has landed in the cross hairs of critics who argue its use encourages doctors to perform more procedures, regardless of need. Cardiologists have fared relatively well under this system, but with the growing emphasis on patient-centered and quality care, this payment model likely will change. And so may compensation.

Sometimes the best-intentioned public policy decisions have unintended consequences. Fee-for-service may be a case in point.

There are many models and scopes of accountable care organizations (ACO). Addressing standardization obstacles and working toward clinical integration are just two of the challenges standing in the way of success.

The American College of Cardiology (ACC) has put in its two cents to the Centers for Medicare & Medicaid Services (CMS) about the Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals for 2013, urging CMS to rework some of its proposed rules, such as dismembering the implementation of a hospitalwide 30-day readmission measure.

To nobodys surprise, the U.S. House of Representatives has passed Minnesota Republican Erik Paulsens bill to repeal the 2.3 percent excise tax on medical devices set to kick in next January as part of the Patient Protection and Affordable Care Act.

CHICAGOAs the world of cardiovascular care continues to transform, hospital administrations constantly look for ways to remain financially viable; however,  the most difficult task may be getting physicians to help share in cost-saving responsibilities. Reginald Blaber, MD, of Lourdes Health System in Camden, N.J., said physicians won't come on board until they know exactly how change will impact quality.

The Canadian healthcare system could avoid annual costs of up to $682 million CAD ($662.4 million USD) if it followed a comprehensive and optimal stroke management regime, according to a study published online May 24 in Stroke. The authors encouraged healthcare decision makers to use the results to guide investments in stroke care systems in Canada and elsewhere.

BOSTONCardiac resynchronization therapy-defibrillator (CRT-D) is an attractive option for mild-to-moderate heart failure (HF) patients. When compared with implantable cardioverter-defibrillators (ICDs), these patients may get more bang for their buck in two wayslower costs and better outcomes, according to an economic analysis of the RAFT trial presented May 11 at the annual scientific sessions of the Heart Rhythm Society.